top of page
Stephen Hyde
Co-Director of the Gene Medicine Research Group
University of Oxford
As Co-Director of the Gene Medicine Research Group his research is focused on the application of gene therapy technologies to provide therapeutic interventions for human disease. During his post-doctoral research at Oxford Stephen was the first to demonstrate that gene transfer could correct the Cystic Fibrosis defect in transgenic mice. This led to an extensive pre-clinical and clinical programme of gene therapy. Products developed in the Gene Medicine Research Group have been evaluated in four gene therapy clinical trials.



Speakers


















































bottom of page